semaglutide litigation Once praised as a breakthrough for diabetes and weight loss, semaglutide—found in drugs like Ozempic, Wegovy, and Rybelsus—is now at the center of growing 🚨 📊 These medications work by mimicking GLP-1 Multi-District Litigation | Updates

This results in huge disparities in the cost of new and old glucose-lowering medications in some countries, limiting access to the full range of diabetes therapies in large segments of the population and creating a two-tiered system of treatment

There is strong evidence from randomised cardiovascular outcome trials (CVOTs) that several long-acting GLP-1 RAs (liraglutide, dulaglutide and subcutaneous semaglutide) provide cardiovascular protection to individuals with T2D with pre-existing cardiovascular disease (secondary prevention) or at high risk of CV events, and to a lesser extent those without overt atherosclerotic vascular disease (primary prevention

Mitochondrial dynamics impacts stem cell identity and fate decisions by regulating a nuclear transcriptional program

Why is CJC-1295 combined with ipamorelin

Use Case Example: A patient presents with high fasting glucose, but no definitive diagnosis is established

There are other causes of B12 deficiency